Qiagen NV - Company Profile

Powered by

All the data and insights you need on Qiagen NV in one report.

  • Save hours of research time and resources with
    our up-to-date Qiagen NV Strategy Report

  • Understand Qiagen NV position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company’s sample technologies help isolate and process DNA, RNA, and proteins from samples such as blood, tissue and other materials; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers products directly and through a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.

Gain a 360-degree view of Qiagen NV and make more informed decisions for your business Gain a 360-degree view of Qiagen NV and make more informed decisions for your business Find out more
Headquarters Netherlands

Address Hulsterweg 82, Venlo, 5912PL


Telephone 31 77 3556600

No of Employees 6,100

Industry Medical Equipment

Ticker Symbol & Exchange QIA (ETR)

Revenue (2023) $2.0B -8.2% (2023 vs 2022)

EPS XYZ

Net Income (2023) XYZ -19.4% (2023 vs 2022)

Market Cap* $9.7B

Net Profit Margin (2023) XYZ -12.1% (2023 vs 2022)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Qiagen NV premium industry data and analytics

130+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

80+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

2

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Qiagen NV (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Qiagen NV’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services
- -
Sample Technologies: Laboratory and Genomic Services
Primary Sample Technology Consumables
XYZ
XYZ
XYZ
Understand Qiagen NV portfolio and identify potential areas for collaboration Understand Qiagen NV portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 New Products/Services In February, the company introduced a new generative AI-driven knowledge base, QIAGEN Biomedical KB-AI.
2024 Plans/Strategy In January, the company announced its plans to open its regional headquarters in Riyadh, Saudi Arabia.
2024 Contracts/Agreements In January, the company and the Ministry of Health of Saudi Arabia signed a memorandum of understanding to cover various public health and infection control initiatives.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Qiagen NV Thermo Fisher Scientific Inc Roche Diagnostics International Ltd Hologic Inc 2invest AG
Headquarters Netherlands United States of America Switzerland United States of America Germany
City Venlo Waltham Rotkreuz Marlborough Heidelberg
State/Province - Massachusetts Zug Massachusetts Baden-Wurttemberg
No. of Employees 6,100 122,000 2,600 6,990 2
Entity Type Public Public Private Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Thierry Bernard Chief Executive Officer; Managing Director Senior Management 2020 58
Roland Sackers Managing Director; Chief Financial Officer Senior Management 2006 54
Lawrence A. Rosen Chairman Non Executive Board 2020 65
Dr. Jonathan Sheldon Head - QIAGEN Digital Insights Business Area; Senior Vice President Senior Management 2018 -
Stephany Foster Head - Human Resources; Senior Vice President Senior Management 2019 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Qiagen NV key executives to enhance your sales strategy Gain insight into Qiagen NV key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?